Literature DB >> 23674618

Protective effects of angiopoietin-like 4 on cerebrovascular and functional damages in ischaemic stroke.

Claire Bouleti1, Thomas Mathivet, Berard Coqueran, Jean-Michel Serfaty, Mathieu Lesage, Elodie Berland, Corinne Ardidie-Robouant, Gilles Kauffenstein, Daniel Henrion, Bertrand Lapergue, Mikael Mazighi, Charles Duyckaerts, Gavin Thurston, David M Valenzuela, Andrew J Murphy, George D Yancopoulos, Catherine Monnot, Isabelle Margaill, Stephane Germain.   

Abstract

AIMS: Given the impact of vascular injuries and oedema on brain damage caused during stroke, vascular protection represents a major medical need. We hypothesized that angiopoietin-like 4 (ANGPTL4), a regulator of endothelial barrier integrity, might exert a protective effect during ischaemic stroke. METHODS AND
RESULTS: Using a murine transient ischaemic stroke model, treatment with recombinant ANGPTL4 led to significantly decreased infarct size and improved behaviour. Quantitative characteristics of the vascular network (density and branchpoints) were preserved in ANGPTL4-treated mice. Integrity of tight and adherens junctions was also quantified and ANGPTL4-treated mice displayed increased VE-cadherin and claudin-5-positive areas. Brain oedema was thus significantly decreased in ANGPTL4-treated mice. In accordance, vascular damage and infarct severity were increased in angptl4-deficient mice thus providing genetic evidence that ANGPTL4 preserves brain tissue from ischaemia-induced alterations. Altogether, these data show that ANGPTL4 protects not only the global vascular network, but also interendothelial junctions and controls both deleterious inflammatory response and oedema. Mechanistically, ANGPTL4 counteracted VEGF signalling and thereby diminished Src-signalling downstream from VEGFR2. This led to decreased VEGFR2-VE-cadherin complex disruption, increased stability of junctions and thus increased endothelial cell barrier integrity of the cerebral microcirculation. In addition, ANGPTL4 prevented neuronal loss in the ischaemic area.
CONCLUSION: These results, therefore, show ANGPTL4 counteracts the loss of vascular integrity in ischaemic stroke, by restricting Src kinase signalling downstream from VEGFR2. ANGPTL4 treatment thus reduces oedema, infarct size, neuronal loss, and improves mice behaviour. These results suggest that ANGPTL4 constitutes a relevant target for vasculoprotection and cerebral protection during stroke.

Entities:  

Keywords:  Acute cerebral infarction; Angiogenesis; Endothelium; Hypoxia; Ischaemia; Vascular biology

Mesh:

Substances:

Year:  2013        PMID: 23674618     DOI: 10.1093/eurheartj/eht153

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  27 in total

Review 1.  Role of Angptl4 in vascular permeability and inflammation.

Authors:  Liang Guo; Shao-Ying Li; Fu-Yun Ji; Yun-Feng Zhao; Yu Zhong; Xue-Jun Lv; Xue-Ling Wu; Gui-Sheng Qian
Journal:  Inflamm Res       Date:  2013-10-31       Impact factor: 4.575

2.  Angiopoietin-like 4: A double-edged sword in atherosclerosis and ischemic stroke?

Authors:  Liang Xu; Zhen-Ni Guo; Yi Yang; Jun Xu; Sherrefa R Burchell; Jiping Tang; Jianmin Zhang; Jing Xu; John H Zhang
Journal:  Exp Neurol       Date:  2015-05-29       Impact factor: 5.330

Review 3.  Intramyocardial haemorrhage after acute myocardial infarction.

Authors:  Ryanne P Betgem; Guus A de Waard; Robin Nijveldt; Aernout M Beek; Javier Escaned; Niels van Royen
Journal:  Nat Rev Cardiol       Date:  2014-11-18       Impact factor: 32.419

4.  Angiopoietin-like 4 stimulates STAT3-mediated iNOS expression and enhances angiogenesis to accelerate wound healing in diabetic mice.

Authors:  Han Chung Chong; Jeremy Soon Kiat Chan; Chi Qin Goh; Natalia V Gounko; Baiwen Luo; Xiaoling Wang; Selin Foo; Marcus Thien Chong Wong; Cleo Choong; Sander Kersten; Nguan Soon Tan
Journal:  Mol Ther       Date:  2014-06-06       Impact factor: 11.454

5.  Angiopoietin-like 4 binds neuropilins and cooperates with VEGF to induce diabetic macular edema.

Authors:  Akrit Sodhi; Tao Ma; Deepak Menon; Monika Deshpande; Kathleen Jee; Aumreetam Dinabandhu; Jordan Vancel; Daoyuan Lu; Silvia Montaner
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

Review 6.  Morphogens and blood-brain barrier function in health and disease.

Authors:  Nienke R Wevers; Helga E de Vries
Journal:  Tissue Barriers       Date:  2015-09-11

7.  Angiopoietin-like 4 promotes angiogenesis in the tendon and is increased in cyclically loaded tendon fibroblasts.

Authors:  Rouhollah Mousavizadeh; Alex Scott; Alex Lu; Gholamreza S Ardekani; Hayedeh Behzad; Kirsten Lundgreen; Mazyar Ghaffari; Robert G McCormack; Vincent Duronio
Journal:  J Physiol       Date:  2016-01-18       Impact factor: 5.182

Review 8.  Current understanding of the molecular and cellular pathology of diabetic retinopathy.

Authors:  David A Antonetti; Paolo S Silva; Alan W Stitt
Journal:  Nat Rev Endocrinol       Date:  2021-01-19       Impact factor: 47.564

9.  Cardiac microvascular barrier function mediates the protection of Tongxinluo against myocardial ischemia/reperfusion injury.

Authors:  Kang Qi; Lujin Li; Xiangdong Li; Jinglin Zhao; Yang Wang; Shijie You; Fenghuan Hu; Haitao Zhang; Yutong Cheng; Sheng Kang; Hehe Cui; Lian Duan; Chen Jin; Qingshan Zheng; Yuejin Yang
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

10.  Differential effects of angiopoietin-like 4 in brain and muscle on regulation of lipoprotein lipase activity.

Authors:  Sara Gry Vienberg; André Kleinridders; Ryo Suzuki; C Ronald Kahn
Journal:  Mol Metab       Date:  2014-11-13       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.